A Phase 2 Study of (99m)Tc-Tilmanocept in the Detection of Sentinel Lymph Nodes in Melanoma and Breast Cancer

BACKGROUND: Several (99m)Tc-labeled agents that are not approved by the U.S. Food and Drug Administration are used for lymphatic mapping. A new low-molecular-weight mannose receptor–based, reticuloendothelial cell-directed, (99m)Tc-labeled lymphatic imaging agent, (99m)Tc-tilmano-cept, was used for...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Leong, Stanley P. L., Kim, Julian, Ross, Merrick, Faries, Mark, Scoggins, Charles R., Rich Metz, Wendy L., Cope, Frederick O., Orahood, Richard C.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2011
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3071527/
https://ncbi.nlm.nih.gov/pubmed/21331809
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-010-1524-z
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi